Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics.

Author:

wang ning1,qu shihui2,kong weiwei1,hua qian1,hong zhihui1,liu zengli1,shi yizhen1

Affiliation:

1. Second Affiliated Hospital of Soochow University

2. Second Affiliated Hospital of Soochow

Abstract

Abstract Purpose In order to establish and validate novel predictive models for predicting bone metastasis (BM) in newly diagnosed prostate adenocarcinoma (PCa) in single-photon emission computed tomography radiomics. Method In a retrospective review of clinical SPECT database, 176 patients (training set: n = 140; validation set: n = 36) who underwent SPECT/CT imaging and histologically confirmed with newly diagnosed PCa from June 2016 to June 2022 were enrolled. Radiomic features were extracted from ROI in a targeted lesion of each patient. Clinical features, including age, t-PSA, and Gleason grades, were included. Statistical tests were then used to eliminate irrelevant and redundant features. Finally, three types of optimized models were constructed for the prediction. Furthermore, 5-fold cross-validation was applied to obtain the sensitivity, specificity, accuracy, and area under the curve (AUC) for performance evaluation. The clinical usefulness of the multivariate models was estimated through decision curve analysis (DCA). Results Radiomics signature consisting of 27 selected features was significantly correlated with bone status(P < 0.01 for both training and validation sets). Collectively, the models showed good predictive efficiency. The AUC values ranged from 0.87 to 0.98 in four models. The AUC value of the human experts was 0.655 and 0.872 in the training and validation groups, respectively. Most radiomic models showed better diagnostic accuracy than human experts in the training group and the validation group. DCA also demonstrated the superiority of the radiomics models compared to human experts. Conclusion Our proposed models, which incorporate SPECT-based radiomics signature and clinical risk factors, could be a promising auxiliary means to assist radiologists or medical physicians in their subsequent workup to confirm the diagnosis of BM.

Publisher

Research Square Platform LLC

Reference26 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021

2. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates;Culp MB;Eur Urol,2020

3. Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence;Norum J;Pharmacoeconomics 2017

4. Chaffer CL, Weinberg RA, Perspective A. on Cancer Cell Metastasis. Science 2011, 331 (6024), 1559–1564.

5. Survival after bone metastasis by primary cancer type: a Danish population-based cohort study;Svensson E;BMJ Open,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3